TBX3 and breast cancer: Overexpression of TBX3 at early pre‐invasive stages (CCL, DCIS) of breast cancer progression, inducing other molecular regulators of EMT (including SLUG and TWIST1), acts as an enabler to set the stage for basement membrane breakdown and invasion into adjacent stroma.